Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rachel Jeitziner"'
Autor:
Jimmy Stalin, Oriana Coquoz, Rachel Jeitziner Marcone, Stephane Jemelin, Nina Desboeufs, Mauro Delorenzi, Marcel Blot-Chabaud, Beat A. Imhof, Curzio Ruegg
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3185 (2023)
The melanoma cell adhesion molecule, shed from endothelial and cancer cells, is a soluble growth factor that induces tumor angiogenesis and growth. However, the molecular mechanism accounting for its generation in a tumor context is still unclear. To
Externí odkaz:
https://doaj.org/article/f0a631bda4254f839a4dd1195c2ebe2b
Autor:
Dalya Ataca, Patrick Aouad, Céline Constantin, Csaba Laszlo, Manfred Beleut, Marie Shamseddin, Renuga Devi Rajaram, Rachel Jeitziner, Timothy J. Mead, Marian Caikovski, Philipp Bucher, Giovanna Ambrosini, Suneel S. Apte, Cathrin Brisken
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
How hormonal signaling in the mammary epithelium controls the surrounding extracellular matrix is unclear. Here, the authors show that a secreted protease, Adamts18, induced by upstream estrogen-progesterone activated Wnt4 in myoepithelial cells, rem
Externí odkaz:
https://doaj.org/article/d8bdc001db1a46d1897587347f7e2b51
Autor:
Marc Pocard, Beat A. Imhof, Oriana Coquoz, Jimmy Stalin, Thomas Matthes, Marine Poittevin, Curzio Rüegg, Rachel Jeitziner, Thomas Alexander Mckee, Philippe Hammel, Stephane Jemelin, Mauro Delorenzi, Rachid Kaci, Marijana Miljkovic-Licina
Publikováno v:
Cancers
Volume 13
Issue 18
Cancers, vol. 13, no. 18, pp. 4625
Cancers, Vol 13, Iss 4625, p 4625 (2021)
Volume 13
Issue 18
Cancers, vol. 13, no. 18, pp. 4625
Cancers, Vol 13, Iss 4625, p 4625 (2021)
Simple Summary Tumor vascularization promotes tumor growth and is intimately connected to immune system function. Despite efforts to use antiangiogenic therapies, their clinical effects are less pronounced than expected. Compensatory angiogenic respo
Autor:
Cathrin Brisken, Rachel Jeitziner, Steve Oudot, Kathryn Hess, Jacques Rougemont, Mathieu Carrière
Publikováno v:
Bioinformatics. 35:3339-3347
Motivation Unbiased clustering methods are needed to analyze growing numbers of complex datasets. Currently available clustering methods often depend on parameters that are set by the user, they lack stability, and are not applicable to small dataset
Autor:
Paolo Angelino, Winald R. Gerritsen, Laura Ciarloni, Rutger H. T. Koornstra, I. Jolanda M. de Vries, Jack A. Schalken, Rachel Jeitziner, Niven Mehra, Victoria Wosika, Sahar Hosseinian Ehrensberger, Tjitske Duiveman-de Boer, Sandra van Wilpe
Publikováno v:
Cancers, 13
Cancers, Vol 13, Iss 4660, p 4660 (2021)
Cancers, 13, 18
Cancers
Volume 13
Issue 18
Cancers, Vol 13, Iss 4660, p 4660 (2021)
Cancers, 13, 18
Cancers
Volume 13
Issue 18
Simple Summary Unfortunately, not all patients with urothelial cancer benefit from checkpoint inhibitors (ICIs). Currently, the first radiological response evaluation is not performed until after 9 to 12 weeks of ICI therapy. Early response biomarker
Autor:
Rachel Jeitziner, S. Hosseinian Ehrensberger, Jack A. Schalken, Paolo Angelino, Laura Ciarloni, V. Wosika, Niven Mehra, S. van Wilpe
Publikováno v:
Annals of Oncology. 31:S596
Publikováno v:
Endocrinology. 156:3442-3450
Worldwide, breast cancer incidence has been increasing for decades. Exposure to reproductive hormones, as occurs with recurrent menstrual cycles, affects breast cancer risk, and can promote disease progression. Exogenous hormones and endocrine disrup
Autor:
Tauno Metsalu, Assya Treboux, Jaak Vilo, Valérian Dormoy, George Sflomos, Jean-François Delaloye, Cathrin Brisken, Ayyakkannu Ayyanan, Wassim Raffoul, Valentina Scabia, Laura Battista, Maryse Fiche, Rachel Jeitziner
Publikováno v:
Cancer Cell
Cancer Cell, Elsevier, 2016, 29 (3), pp.407-422. ⟨10.1016/j.ccell.2016.02.002⟩
Cancer Cell, Elsevier, 2016, 29 (3), pp.407-422. ⟨10.1016/j.ccell.2016.02.002⟩
Summary Seventy-five percent of breast cancers are estrogen receptor α positive (ER + ). Research on these tumors is hampered by lack of adequate in vivo models; cell line xenografts require non-physiological hormone supplements, and patient-derived
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4507f22ca97dbde4cf7e0b9e2c6487a
https://hal.univ-reims.fr/hal-02431957
https://hal.univ-reims.fr/hal-02431957